SB-773812 Administered In Adults With Schizophrenia
Clinical trial NCT00259870 · COMPLETED
Trial details
- NCT number
- NCT00259870
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.